[One-stage surgery in patients with both cardiac and non-cardiac diseases]

Y Yang1, F Xiao1, J Wang1

  • 1Department of Cardiac Surgery, Peking University First Hospital, Beijing 100034, China.

Insights

One-stage cardiac and non-cardiac surgery is feasible and safe for patients with combined conditions. This approach offers satisfactory short-term and long-term survival rates, demonstrating its clinical viability.

Area of Science:

  • Cardiovascular Surgery
  • Surgical Oncology
  • Multispecialty Surgical Procedures

Background:

  • Patients with concurrent cardiac and non-cardiac diseases often require complex management.
  • Simultaneous surgical intervention presents unique challenges and potential benefits.

Purpose of the Study:

  • To evaluate the safety and feasibility of performing one-stage combined cardiac and non-cardiac surgery.
  • To assess short-term and long-term outcomes in patients undergoing this combined approach.

Main Methods:

  • A retrospective analysis of 111 patients who underwent one-stage cardiac and non-cardiac surgery between July 1999 and August 2018.
  • Patient data included cardiac conditions (e.g., coronary heart disease, valvular heart disease) and non-cardiac diseases (e.g., lung cancer, breast cancer, digestive tract malignancies).

Main Results:

  • The hospital mortality rate was 1.8% (2 out of 111 patients).
  • Overall operative morbidity was 11.7%, with complications including hemorrhage, pulmonary infection, and renal failure.
  • Follow-up data showed no cardiogenic deaths, with 21 deaths due to tumor recurrence within 1-5 years.

Conclusions:

  • One-stage combined cardiac and non-cardiac surgery is a safe and viable option for select patients.
  • This approach demonstrates satisfactory short-term and long-term survival outcomes, particularly in managing malignant conditions.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
97
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
104
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
414
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
76
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
121
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
119